• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Tumor Sensitization to Purine Analogs by E. coli PNP

        互联网

        618
        This chapter describes an approach to destroying malignant cells by effectively changing the tumor phenotype through the delivery of Escherichia coli purine nucleo-side phosphorylase (PNP). In the presence of nucleoside prodrugs, this nonhuman enzyme in purine metabolism causes the death of the transfected (transduced) cells through the release of a highly potent antitumor agent. Importantly, the properties of the liberated compounds kill not only the transfected (transduced) cells but cause the efficient destruction of tumor cells that do not express the gene (i.e., bystander cells). In addition, the cytotoxic agents are active against both proliferating and nonproliferating tumor cells and, therefore, unlike other antitumor agents, this system can target the nonproliferating component of solid tumors. Many common cancers (including prostate, breast, colon, lung, brain, melanoma, pancreas, ovarian, kidney) progress to become untreatable and eventually cause death. Compounds are available that could abolish these tumors, but they are too toxic to systematically administer safely to cancer patients. We have shown that some of these compounds are remarkably potent and can abolish otherwise refractory human cancers when produced within the tumor mass by virtue of expression of E. coli PNP.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序